Further report on prophylatic lithium in recurrent affective disorders.
D000328:Adult; D000342:Affective Symptoms / Q000517:prevention & control*; D000367:Age Factors; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D005260:Female; D006760:Hospitalization; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced / Q000188:drug therapy; D007902:Length of Stay; D008094:Lithium / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D008593:Menopause; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D012008:Recurrence; D012737:Sex Factors; D013974:Thyroxine / Q000627:therapeutic use; D013997:Time Factors
D008094:Lithium; D013974:Thyroxine; D002118:Calcium